苯丙酸诺龙

{{Drugbox
| Verifiedfields =
| Watchedfields =
| verifiedrevid =
| IUPAC_name = [(8R,9S,10R,13S,14S,17S)-13-methyl-3-oxo-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl] 3-phenylpropanoate
| image = Nandrolone phenylpropionate.svg
| width = 250px
| image2 = Nandrolone phenylpropionate molecule ball.png
| width2 = 250px

| tradename = Durabolin, others
| pregnancy_AU = D
| pregnancy_US = X
| pregnancy_category =
| legal_AU = S4
| legal_CA = Schedule IV
| legal_UK = Class C
| legal_US = Schedule III
| legal_status =
| routes_of_administration = Intramuscular injection
| class = Androgen; Anabolic steroid; Androgen ester; Progestogen

| bioavailability = • Oral: 0.3–2.9% (pigs)
• Intramuscular: high
| protein_bound =
| metabolism = Blood (hydrolysis), liver (reduction)
| metabolites = • Nandrolone
• 19-Noretiocholanolone
• Nandrolone: 。这类药物过去曾广泛应用，但现已逐渐停用。
（Nandrolone，诺龙），NPP的最终活性形式]]
参考文献